Let's see.... 600 million in sales, 445 of that was Latuda 6 million in Lonhala, almost as much as Xopenex is down to nothing new to be launched this year dasotraline for BED possible 2020, how big is that market and what coverage will we have? Actual sales down, except for price increase Tick, tock, tick, tock.................
Still no respiratory jobs posted and people continue leaving. 6 million in sales for the Q1 ... why wait, just get on with it already sunovion. You've canned the leader of the pack, financials are in, not rehiring ... what seems to be the issue here? Perhaps high level meetings deciding on how the restructure will be handled. Based on the progression of events, I'm thinking 2-4 weeks, and it will be mostly NAS reps with a job.
Golden Handcuffs. Most respiratory reps are looking for opportunities with comparable incomes. When they find it ... they leave. Sunovion respiratory is a lose/lose proposition and everyone knows it and looking to get out !!
